Edesa Biotech Publishes Phase 2 Substudy Results of ARDS Drug Candidate

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/3/2026

1. KRG
2. ALAR
3. CCH:LN
4. META
5. CCHGY
6. PRY:IM
7. PRYMY
8. SPY
9. SKA-B
10. PBA

Go back to Edesa Biotech Publishes Phase 2 Substudy Results of ARDS Drug Candidate
(NASDAQ: EDSA) Delayed: 7.50 -0.25 (3.23%)
Previous Close $7.75    52 Week High $ 
Open $7.61    52 Week Low $ 
Day High $7.98    P/E N/A 
Day Low $7.24    EPS $ 
Volume 68,267